Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities
- PMID: 37041350
- DOI: 10.1208/s12249-023-02555-2
Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities
Abstract
Glioblastoma multiforme (also known as glioblastoma; GBM) is one of the most malignant types of brain tumors that occurs in the CNS. Treatment strategies for glioblastoma are majorly comprised of surgical resection, radiotherapy, and chemotherapy along with combination therapy. Treatment of GBM is itself a tedious task but the involved barriers in GBM are one of the main impediments to move one step closer to the treatment of GBM. Basically, two of the barriers are of utmost importance in this regard, namely blood brain barrier (BBB) and blood brain tumor barrier (BBTB). This review will address different challenges and barriers in the treatment of GBM along with their etiology. The role and recent progress of lipid-based nanocarriers like liposomes, solid lipid nanocarriers (SLNs), nanostructured lipid carriers (NLCs), lipoplexes, and lipid hybrid carriers in the effective management of GBM will be discussed in detail.
Keywords: BBB; GBM; challenges; drug delivery; lipid nanocarriers; solid lipid nanoparticles.
© 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Similar articles
-
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme.Pharmaceutics. 2020 Sep 10;12(9):860. doi: 10.3390/pharmaceutics12090860. Pharmaceutics. 2020. PMID: 32927610 Free PMC article. Review.
-
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment.Biomed Pharmacother. 2024 Feb;171:116113. doi: 10.1016/j.biopha.2023.116113. Epub 2024 Jan 5. Biomed Pharmacother. 2024. PMID: 38181717 Review.
-
A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.Drug Deliv. 2019 Dec;26(1):551-565. doi: 10.1080/10717544.2019.1616235. Drug Deliv. 2019. PMID: 31928355 Free PMC article. Review.
-
Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells.Biomed Mater. 2024 Aug 22;19(5). doi: 10.1088/1748-605X/ad6e47. Biomed Mater. 2024. PMID: 39134023
-
Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?Drug Deliv. 2016 Nov;23(9):3408-3416. doi: 10.1080/10717544.2016.1189465. Epub 2016 Jun 8. Drug Deliv. 2016. PMID: 27181462
Cited by
-
Nanotherapy of Glioblastoma-Where Hope Grows.Int J Mol Sci. 2025 Feb 20;26(5):1814. doi: 10.3390/ijms26051814. Int J Mol Sci. 2025. PMID: 40076445 Free PMC article. Review.
-
Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies.Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9243-9279. doi: 10.1007/s00210-024-03212-6. Epub 2024 Jul 4. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38963550
-
In Vitro and In Vivo Evaluation of Lactoferrin-Modified Liposomal Etomidate with Enhanced Brain-Targeting Effect for General Anesthesia.Pharmaceutics. 2024 Jun 14;16(6):805. doi: 10.3390/pharmaceutics16060805. Pharmaceutics. 2024. PMID: 38931926 Free PMC article.
References
-
- WHO Fact Sheet [Internet]. [cited 2022 Mar 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
-
- SEER Cancer Stat Facts [Internet]. [cited 2022 Mar 9]. Available from: https://seer.cancer.gov/statfacts/
-
- Brain Tumor: Introduction | Cancer.Net [Internet]. [cited 2022 Mar 9]. Available from: https://www.cancer.net/cancer-types/brain-tumor/introduction
-
- Gutkin A, Cohen ZR, Peer D. Harnessing nanomedicine for therapeutic intervention in glioblastoma. Expert Opin Drug Deliv [Internet]. 2016;13:1573–82. https://doi.org/10.1080/17425247.2016.1200557 . (Taylor & Francis). - DOI - PubMed
-
- Urbanska K, Sokolowska J, Szmidt M, Sysa P. Glioblastoma multiforme – an overview. Contemp Oncol [Internet]. Termedia Publishing; 2014 [cited 2022 Mar 9];18:307. Available from: /pmc/articles/PMC4248049/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical